A reputable provider will encourage you to discuss the treatment with your OB-GYN and may even offer to communicate directly with your prenatal care team
10.1210/er.2015-1098 [DOI] [PMC free article] [PubMed] [Google Scholar] 6.Furmaniak J, Sanders J, Rees Smith B
Theoretical Risks with Chronic Use Some concerns raised by clinicians and researchers include: Unregulated angiogenesis: Overstimulation of blood vessel growth could hypothetically support tumor progression in cancer-prone individuals Unknown hormonal crosstalk: While BPC-157 is non-hormonal, it interacts with systems (e.g., nitric oxide, dopamine) that may influence downstream signaling Immune tolerance or desensitization: Chronic exposure to any peptide could alter immune recognition or receptor sensitivity over time These concerns are theoretical , but they highlight why BPC-157 should not be used indefinitely or in uncontrolled cycles
S2-S3, Table S1a)
You're not the first one who was unsure see how it went for others
HETEROLOGOUS EXPRESSION OF AsGGT1, AsGGT2, AND AsGGT3 IN YEAST The coding regions of AsGGT1 , AsGGT2 , and AsGGT3 were amplified by PCR using the cloned cDNA fragments described above, KOD plus DNA polymerase (Toyobo), and the following gene-specific primers: AsGGT1-FKpn3A (5- GGTACC AAAATGAACCAAATGGCGCCGGCTTC-3) and AsGGT1-stop-RXh (5- CTCGAG CTATACACAAGCAGGACTTC CATC-3) for AsGGT1
